Cargando…

Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19

According to numerous recent publications, the COVID-19 patients have lymphopenia, higher infection-related biomarkers and several elevated inflammatory cytokines (i.e. tumor necrosis factor (TNF)-α, interleukin IL-2R and IL-6). The total number of B cells, T cells and NK cells are significantly dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Athina, Alexandris, Nikos, Konstantinou, Evangelia, Mesiakaris, Konstantinos, Zanidis, Charilaos, Farsalinos, Konstantinos, Poulas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309930/ https://www.ncbi.nlm.nih.gov/pubmed/32846644 http://dx.doi.org/10.1016/j.envres.2020.109858

Ejemplares similares

Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy
por: Poulas, Konstantinos, et al.
Publicado: (2020)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021)

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020)

Response to McMahon et al's “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases”
por: Poulas, Konstantinos, et al.
Publicado: (2022)

Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
por: Tanmay, Saraiya, et al.
Publicado: (2021)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? A Risk-Assessment Analysis of Currently Available Literature
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)

Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health
por: Isik Andrikopoulos, Gozde, et al.
Publicado: (2019)

Microcurrent Stimulation Triggers MAPK Signaling and TGF-β1 Release in Fibroblast and Osteoblast-Like Cell Lines
por: Konstantinou, Evangelia, et al.
Publicado: (2020)

The Toll‐like receptor 7 agonist imiquimod increases ethanol self‐administration and induces expression of Toll‐like receptor related genes
por: Lovelock, Dennis F., et al.
Publicado: (2022)

Tobacco-Specific Nitrosamines in Electronic Cigarettes: Comparison between Liquid and Aerosol Levels
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)

Real-Time Assessment of E-Cigarettes and Conventional Cigarettes Emissions: Aerosol Size Distributions, Mass and Number Concentrations
por: Lampos, Spyros, et al.
Publicado: (2019)

Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Patterns of flavored e-cigarette use among adult vapers in the USA: an online cross-sectional survey of 69,233 participants
por: Farsalinos, Konstantinos, et al.
Publicado: (2023)

Electronic cigarette use in Greece: an analysis of a representative population sample in Attica prefecture
por: Farsalinos, Konstantinos E., et al.
Publicado: (2018)

Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication
por: Farsalinos, Konstantinos, et al.
Publicado: (2021)

Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

TA-GC cloning: A new simple and versatile technique for the directional cloning of PCR products for recombinant protein expression
por: Niarchos, Athanasios, et al.
Publicado: (2017)

Combined Toxicity of Cannabidiol Oil with Three Bio-Pesticides against Adults of Sitophilus Zeamais, Rhyzopertha Dominica, Prostephanus Truncatus and Trogoderma Granarium
por: Mantzoukas, Spiridon, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
por: Zhang, Li, et al.
Publicado: (2015)

Toll-like Receptor 7 (TLR7) Is Expressed in Adipocytes and the Pharmacological TLR7 Agonist Imiquimod and Adipocyte-Derived Cell-Free Nucleic Acids (cfDNA) Regulate Adipocyte Function
por: Thomalla, Miriam, et al.
Publicado: (2022)

Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers)
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)

Corrigendum: Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers)
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)

Electronic cigarettes: an aid in smoking cessation, or a new health hazard?
por: Farsalinos, Konstantinos
Publicado: (2017)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

Nicotine Levels and Presence of Selected Tobacco-Derived Toxins in Tobacco Flavoured Electronic Cigarette Refill Liquids
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Lessons and Guidance from the Special Issue on Electronic Cigarette Use and Public Health
por: Sumner, Walton, et al.
Publicado: (2018)

Toxicity classification of e-cigarette flavouring compounds based on European Union regulation: analysis of findings from a recent study
por: Farsalinos, Konstantinos, et al.
Publicado: (2019)

Speculation vs. evidence in the association between e-cigarette use and COVID-19: A response to Soule et al
por: Farsalinos, Konstantinos, et al.
Publicado: (2021)

E-Cigarette Use and COVID-19: Questioning Data Reliability
por: Farsalinos, Konstantinos, et al.
Publicado: (2021)

Correction to: A tale of flawed e‑cigarette research undetected by defective peer review process
por: Polosa, Riccardo, et al.
Publicado: (2022)

A tale of flawed e-cigarette research undetected by defective peer review process
por: Polosa, Riccardo, et al.
Publicado: (2022)

Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
por: Avcilar, Huseyin, et al.
Publicado: (2020)

Folic Acid-Functionalized, Condensed Magnetic Nanoparticles for Targeted Delivery of Doxorubicin to Tumor Cancer Cells Overexpressing the Folate Receptor
por: Angelopoulou, Athina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ikj77m4tbj7v7da2l9cg89c9te